Calcinosis in juvenile dermatomyositis, a therapeutic challenge;Calcinose na infância, um desafio terapêutico

Revista Brasileira de Reumatologia

Volumn 47, Issue 1, 2007, Pages 63-68

  de Castro, Tânia Caroline Monteiro ^a,b   Yamashita, Edson ^a   Terreri, Maria Teresa R A ^a   Len, Claúdio Arnaldo ^a   Hilário, Maria Odete Esteves ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Alendronate; Calcinosis; Diltiazen; Immunoglobulin; Juvenile dermatomyositis

Indexed keywords

ALENDRONIC ACID; ANTINUCLEAR ANTIBODY; CLARITHROMYCIN; CREATINE KINASE; DILTIAZEM; DNA ANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE SEVERITY; FEMALE; HUMAN; JUVENILE DERMATOMYOSITIS; LABORATORY TEST; MALE; PATHOPHYSIOLOGY; SCHOOL CHILD; SKIN CALCIFICATION;

EID: 39649090687     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042007000100013     Document Type: Article

References (39)

1. Ramanan AV, Feldman BM: Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 28: 833-57, 2002.
2. Boulman N, Slobodin G, Rozenbaum M, Rosner I: Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34: 805-12, 2005.
3. Mukamel M, Horev G, Mimouni M: New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138: 763-6, 2001.
4. Ansell BM: Juvenile dermatomyositis. Rheum Dis Clin North Am 17: 931-42, 1991.
5. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP: Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47: 505-11, 2002.
6. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT: Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcification. J Pediatr 103: 882-8, 1983.
7. Martinez-Cordero E, Lopez-Zepeda J, Choza-Romero F: Calcinosis in childhood dermatomyositis (letter). Clin Exp Rheumatol 8: 198-200, 1990.
8. Berger RG, Featherstone GL, Raasch RH, McCartney WH, Hadler NM: Treatment of calcinosis universalis with low-dose warfarin. Am J Med 83: 72-6, 1987.
9. Aihara J, Mori M, Ibe M, et al: A case of juvenile dermatomyositis with calcinosis universalis. Remarkable improvement with aluminum hydroxide therapy. Ryumachi 34: 879-84, 1994.
10. Dent CE, Stamp TCB: Treatment of calcinosis circumscripta with probenecid. BMJ 1: 216-8, 1972.
11. Ambler GR, Chaitow J, Rogers M, McDonald DW, Ouvrier RA: Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 32: 1837-9, 2005.
12. Romero KT, Terreri MT, Len CA, Hilário MO: Dermatomiosite e polimiosite juvenis: Diagnóstico e tratamento. Rev Paul Pediatria 21: 223-7, 2003.
13. Wananukul S, Pongprasit P, Wattanakrai P: Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: Report of two cases. Aust J Dermatol 58: 202-5, 1997.
14. Sogabe T, Silva CAA, Kiss MH: Clinical and laboratorial characteristics of 50 children with dermato/polymyositis. Rev Bras Reumatol 36: 351-8, 1996.
15. Buyse G, Silberstein J, Goemans N, Casaer P: Fibrodysplasia ossificans progressiva: still turning into wood after 300 years? Eur J Pediatr 154: 694-9, 1995.
16. Miyamae T, Mori M, Inamo Y, et al: Multi-center analysis of calcinosis in children with juvenile dermatomyositis. Ryumachi 43: 538-43, 2003
17. Ichiki Y, Akiyama T, Shimozawa N, Suzuki Y, Kondo N, Kitajima Y: An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol 144: 894-7, 2001.
18. Liniger P, Slongo T, Eckhardt O: Tumoral calcinosis and atypical juvenile dermatomyositis: case report. Eur J Pediatr Surg 8: 382-4, 1998.
19. Murphy E, Freaney R, Bresnihan B, McKenna M, Fitzgerald O: Evidence for increased bone turnover in patients with dystrophic calcification. Arthritis Rheum 39: S97, 1996.
20. Metzger AL, Singer FR, Bluestone R, Pearson CM: Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 291: 1294-6, 1974.
21. Castro GRW, Sampaio-Barros PD, Appenzeller S, Marques Neto JF, Samara AM: Uso do clodronato endovenoso na calcinose difusa em uma criança corn síndrome de superposição esclerose sistêmica e dermatomiosite. Rev Bras Reumatol 44: 90-3, 2004.
22. Fleish H: Bisphosphonates: mechanism of action. Endocr Rev 19: 80-100, 1998.
23. Bianchi M, Cimaz R, Bardare M, et al: Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse conective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 43: 1960-6, 2000.
24. Rudge S, Hailwood S, Horne A, Lucas J, Wu F, Cundy T: Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology 44: 813-8, 2005.
25. Glorieux F, Bishop N, Plotkin H, Chabot G, Lanoue G, Travers R: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947-52, 1998.
26. Oliveri MB, Palermo R, Mautalen C, Hubscher O: Regression of calcinosis during diltiazen treatment in juvenile dermatomyositis. J Rheumatol 23: 2152-5, 1996.
27. Ruetter A, Luger TA: Efficacy and safety of intravenous immunoglobulin for immune-mediate skin disease. Am J Clin Dermatol 5: 153-60, 2004.
28. Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM: Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27: 2498-503, 2000.
29. Vedanarayanan V, Subramony SH, Ray LI, Evans OB: Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin. Pediatr Neurol 13: 336-9, 1995.
30. Cherin P, Piette JC, Wechsler B, et al: Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 21: 1092-7, 1994.
31. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM: Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91: 169-72, 1991.
32. Bodemer C, Teillac D, Le Bourgeois M, et al: Efficacy of intravenous immunoglobulins in sclerodermatomyositis. Br J Dermatol 123: 545-51, 1990.
33. Olson NY, Lindsley CB: Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 16: 1545-7, 1989.
34. Zeller V, Cohen P, Prieur AM, Guillevin L: Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J Rheumatol 23: 1424-7, 1996.
35. Fuchs D, Fruchter L, Fishel B, Holtzman M, Yaron M: Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 5: 527-30, 1986.
36. Vereecken P, Stallenberg B, Tas S, de Dobbeleer G, Heenen M: Ulcerated dystrophic calcinosis cutis secondary to localised linear scleroderma. Int J Clin Pract 52: 593-4, 1998.
37. Maillard SM, Wilkinson N, Riley P, Beresford M, Davidson J, Murray KJ: The treatment of persistent severe idiopathic inflammatory myositis with anti-TNFalpha therapy. Arthritis Rheum 46 (suppl): S 307, 2002.
38. Hazen PG, Walker AE, Carney JF, Stewart JJ: Cutaneous calcinosis of scleroderma: successful treatment with intralesional adrenal steroids. Arch Dermatol 118: 366-7, 1982.
39. Rider LG: Calcinosis in juvenile dermatomyositis: pathogenesis and current therapies. Pediatric Rheumatology Online Journal. Modified from Presentation, "Treatment of Refractory Juvenile Dermatomyositis", 66th Annual American College of Rheumatology Meeting, October 2002, New Orleans.